A 32-year-old woman with poorly controlled diabetes mellitus (HbA1c 11.2%) presents with vulvovaginal candidiasis. She has completed a 7-day course of topical clotrimazole with minimal symptom relief. On examination, thick white plaques are noted on the vaginal wall. What is the most appropriate next step in management?

Explanation

## Clinical Context This patient has recurrent or persistent vulvovaginal candidiasis (VVC) despite topical azole therapy. The poor glycemic control (HbA1c 11.2%) is a major predisposing factor, and the failure of topical therapy suggests the need for systemic antifungal treatment. ## Rationale for Oral Fluconazole **Key Point:** Oral fluconazole 150 mg as a single dose is the first-line systemic therapy for uncomplicated VVC, especially when topical therapy has failed. **High-Yield:** A single oral dose of fluconazole achieves high vaginal concentrations and has cure rates of 80–90% in uncomplicated candidiasis. It is superior to repeated topical therapy in treatment-resistant cases. **Clinical Pearl:** The underlying cause (uncontrolled diabetes) must be addressed simultaneously. Glycemic optimization reduces Candida colonization by lowering glucose in vaginal secretions and improving immune function. ## Why This Approach Works | Feature | Topical Azoles | Oral Fluconazole | |---------|---|---| | Efficacy in treatment-naive VVC | 80–90% | 85–95% | | Efficacy in treatment-resistant VVC | Poor | Excellent | | Systemic bioavailability | Minimal | High | | Single-dose convenience | No | Yes | | Cost-effective | Yes | Moderate | **Mnemonic:** **FLUCON** = **F**irst-line, **L**ow-dose, **U**ncomplicatedVVC, **C**onvenient single dose, **O**ral route, **N**o resistance in Candida albicans (yet). ## Management Algorithm ```mermaid flowchart TD A[Vulvovaginal candidiasis]:::outcome --> B{Topical azole response?}:::decision B -->|Yes| C[Continue topical therapy]:::action B -->|No| D[Uncomplicated or complicated?]:::decision D -->|Uncomplicated| E[Oral fluconazole 150 mg single dose]:::action D -->|Complicated<br/>recurrent/severe| F[Fluconazole 150 mg day 1, then weekly x 6 months]:::action E --> G[Address underlying causes<br/>optimize glycemic control]:::action F --> G G --> H[Symptom resolution + prevention]:::outcome ``` **Key Point:** Concurrent glycemic optimization is essential; without it, recurrence is likely even after successful antifungal treatment.